PKKK/300/UP/052 Screening of Clindamycin by HPLC
- Tapis semua fasa bergerak (akueus dan organik) menggunakan penuras membran 0.45 µm dan degas dalam kukus ultrasonik selama sekurang-kurangnya 15–20 minit.
- Lakukan Auto Purge / Manual Purge setiap kali pelarut ditambah atau ditukar jenis bagi menyingkirkan buih udara.
- Pastikan garisan dasar (baseline) dan tekanan pam stabil (RSD < 2%) sebelum memulakan suntikan sampel kelompok.
- Bagi sampel matriks kapsul lembut (softgel), gunakan Chloroform kerana gelatin/minyak tidak larut dalam Methanol.
|
NPRA PUSAT KAWALAN KUALITI |
ARAHAN KERJA: SCREENING OF CLINDAMYCIN BY HPLC | |
| No. Dokumen: PKKK/300/UP/052 | Terbitan / Semakan: Terbitan 3 Semakan 0 | |
| Tarikh Kuatkuasa: 10 April 2026 | Bahagian / Unit: SPPK · Unit Penyaringan | |
0.0 SEJARAH PINDAAN & SEMAKAN
AMENDMENT :
This procedure is a new document in line with upgrading the institution’s certification to the ISO 9001: 2015 version and the renaming of the institution from National Pharmaceutical Control Bureau (NPCB) to Bahagian Regulatori Farmasi Negara (NPRA). Therefore, the original document is obsolete and this document is published as Version 1.
HISTORY OF REVISION :
Issue 2 Revision 0 :
Update on document number from PKK/200/KOS/022 to PKK/200/HMS/010
Update on effective date from 15 November 2016 to 10 February 2020
Update on responsibility.
Issue 3 Revision 0 :
Document change from testing procedure PKK/200/HMS/010 to work instruction PKK/300/HMS/065
Issue 3 Revision 1 :
i. Update on name of agency from National Pharmaceutical Regulatory Agency (NPRA) to Bahagian Regulatori Farmasi Negara (NPRA)
Issue 4 Revision 0 :
Update document number from PKK/300/HMS/065 to PKKK/300/HMS/065
Update paragraph 5.0 Responsibility
Issue 5 Revision 0 :
i. Update document number from PKKK/300/HMS/065 to PKKK/300/KOS/022
ii. Update paragraph 5.0 Responsibility
Update paragraph 7. Quality Records
Issue 5 Revision 1:
i. Update document number from PKKK/300/KOS/022 to PKKK/300/UP/052
Sejarah Pindaan & Semakan Dokumen (5 entri) ▸
ii. Pinda tarikh kuatkuasa 1 April 2024 kepada 10 April 2026.
iii. Kemaskini para 7.0 Quality Records :
KOS/X003 kepada UP/X009
KOS/X009 to UP/X013
KOS/002A kepada UP/002B
1.0 OBJECTIVE
◼ To screen the presence of clindamycin in cosmetic products using HPLC.
2.0 SCOPE
◼ This test method is only to be used for screening of clindamycin in cosmetic products which is suspected to contain the substance.
4.0 FLOW CHART
Responsibility
Head of Section
Head of Unit / Pharmacist in Charge
Distribute samples for testing to Pharmacist through QUEST system
Validate and approve analysis report on QUEST system
Review investigation report of failed samples
Pharmacist
Distribute samples for testing among analysts
Ensure tests are conducted according to laboratory protocols
Review analysis reports and update into the QUEST system
Investigate and report failed samples
Perform sample analysis (when necessary) and report
Pharmacy assistant / Analyst
Perform sample analysis and report
6.0 PROCEDURE
High Pressure Liquid Chromatograph with a variable visible wavelength detector
Whatman PTFE disposable syringe filter, 13 mm diameter, 0.45 µm pore size or equivalent
Nylon filter, 47 mm diameter, 0.45 µm pore size or equivalent
Ultrasonic bath
10ml volumetric flask
20ml volumetric flask
Methanol (HPLC grade)
Sodium Dihydrogen Phosphate (NaH2PO4)
Water used must be Ultrapure water, 18 mega ohm
Orthophosphoric acid 85% (H3PO4)
0.01M Phosphate Buffer Solution adjusted with orthophosphoric acid to pH 2.5
Solvent: Mobile phase
Reference material: Clindamycin phosphate standard
Chromatographic Parameters
◼ Column : uBondapak C18 125A, 300 mm x 3.9 mm i.d., 10 µm
◼ System : Isocratic
◼ Mobile phase : 0.01M Phosphate buffer solution pH 2.5/methanol with 50:50 (v/v)
◼ Temperature : 40oC
◼ Flow rate : 0.8 mL/min
◼ Detection : UV, 205 nm
◼ Injection volume : 20 μl
Preparation of 0.01M Phosphate buffer solution ph 2.5
6.0 PROCEDURE
Reference Standard Preparation
Note: The weight of reference standard can be modified to minimize
the usage of the reference standard.
Sample Preparation
Note: The weight of sample can be modified due to the availability and situation of the sample received.
Measurement
Results
Compare the retention time obtained from the sample chromatogram with that of the Clindamycin Phosphate standards.
The identity test is positive if the retention time of the sample is identical to that obtained from the standard chromatogram.
7.0 QUALITY RECORDS
Rumusan Laporan Pengujian Kromatografi : UP/X009
Keputusan Ujian Kosmetik : UP/X013
Laporan Siasatan Sampel Tidak Lulus Ujian Kromatografi : UP/002B
8.0 ATTACHMENTS
Chromatogram of Reference Standard
Chromatogram of System Suitability test
Chromatogram of Reference Standard
Chromatogram of System Suitability Test
Jadual Kromatografi & Rujukan Data
| HISTORY OF REVISION | HISTORY OF REVISION | HISTORY OF REVISION | HISTORY OF REVISION | HISTORY OF REVISION | HISTORY OF REVISION |
|---|---|---|---|---|---|
| Issue | Revision | Written by | Reviewed by | Approved by | Effective date |
| 1 | 0 | Nor Izyani Hanafi | Ooi Suat Hong | Dr Noraida Mohamad Zainoor | 15 November 2016 |
| 2 | 0 | Nor Izyani Hanafi | Ooi Suat Hong | Wan Nurul Aina Mior Abdullah | 10 February 2020 |
| 3 | 0 | Nor Izyani Hanafi | Ooi Suat Hong | Wan Nurul Aina Mior Abdullah | 15 July 2020 |
| 3 | 1 | Nor Izyani Hanafi | Ooi Suat Hong | Wan Nurul Aina Mior Abdullah | 15 Disember 2020 |
| 4 | 0 | Gopinatha Ganesh | Nor Izyani Hanafi | Wan Nurul Aina Mior Abdullah | 1 November 2022 |
| 5 | 0 | Leong Lip Wai | Gopinatha Ganesh | Nor Izyani Hanafi | 1 April 2024 |
| 5 | 1 | Gopinatha Ganesh | Tan Lu Yi | Ida Syazrina Ibrahim | 10 April 2026 |
| REFERENCE | REFERENCE |
|---|---|
| Document No. | Title |
| USP Monograph 33 |